Related Experiment Video
Updated: May 14, 2026
08:59
Neutrophil Extracellular Traps Generated by Low Density Neutrophils Obtained from Peritoneal Lavage Fluid Mediate Tumor Cell Growth and Attachment
Published on: August 3, 2018
Tumor-Derived Exosomal Fatty Acids Reprogram Neutrophils to Drive Neutrophil Extracellular Traps Formation and Lung
Lulu Han1,2,3, Yuxin Chen1,2,3, Ruchen Wu1
1Cancer Institute, Xuzhou Medical University, 209 Tongshan Road, Xuzhou 221004, China.
Research (Washington, D.C.)
|May 13, 2026
Summary
Lung cancer exosomes reprogram neutrophils using fatty acids, promoting tumor growth via NETs. Targeting Rab34 or NETs may offer new lung cancer therapies.
Area of Science:
- Oncology
- Immunology
- Metabolism
Background:
- Neutrophils infiltrate tumors and drive cancer progression.
- Mechanisms of neutrophil reprogramming by cancer remain unclear.
Purpose of the Study:
- Investigate how lung cancer-derived exosomes (LDEs) reprogram neutrophils.
- Identify molecular pathways involved in LDE-mediated neutrophil activation.
Main Methods:
- Exosome isolation and characterization.
- Neutrophil isolation and treatment with LDEs.
- Analysis of neutrophil metabolism and function (lipid accumulation, FAO, ROS, NETs).
- Rab34 knockdown in neutrophils.
- In vivo lung cancer models.
- NETs degradation assays.
Main Results:
- LDEs deliver free fatty acids to neutrophils, inducing metabolic changes (lipid accumulation, FAO, ROS).
- This reprogramming enhances neutrophil extracellular trap (NETs) formation, accelerating lung cancer growth.
- Ras-related protein Rab-34 (Rab34) regulates LDE uptake by neutrophils.
- Rab34 knockdown significantly reduced LDE-induced metabolic reprogramming and NETs formation, mitigating tumor progression.
- NETs degradation confirmed their essential role in lung cancer growth.
Conclusions:
- LDEs reprogram neutrophils via exosomal free fatty acids in a Rab34-dependent manner.
- This process promotes lung cancer progression through enhanced NETs formation.
- Rab34 and NET-associated pathways represent potential therapeutic targets for lung cancer.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...